MIT-002

N/A

Report date: 2023/11/02 09:22:56
NME

Base Information

Drug NameMIT-002
Drug Alias NameMIT-002
ClassificationSmall molecules
Mechanisms of ActionOxygen radical scavengers
TargetsUpdating
Therapy Area/IndicationsMacular DegenerationLiver CirrhosisMetabolic Dysfunction-Associated Steatotic Liver Disease +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMitoImmune Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesMitoImmune Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsMacular DegenerationLiver CirrhosisMetabolic Dysfunction-Associated Steatotic Liver Disease +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A